A hidden asteroid family may share Venus' orbit: 'It's like discovering a continent you didn't know existed'
Astronomers are investigating a little-known and largely unseen group of asteroids that quietly orbit the sun alongside Venus — and there may be many more of them than we thought.
"It's like discovering a continent you didn't know existed," Valerio Carruba of the São Paulo State University in Brazil, who led the analysis, told Space.com. "It's very likely there are other asteroids we don't observe today."
These space rocks, known as "Venus co-orbital asteroids," are a special class of asteroids that move in lockstep with the planet, sharing its orbit around the sun. To date, only about 20 have been confirmed — but a new study conducted by Carruba and his colleagues suggests many more may be lurking just out of sight.
Most Venus co-orbital asteroids are exceptionally difficult to detect from Earth. They appear close to the sun in the sky, an area where ground-based telescopes have limited visibility. Even under ideal conditions, their rapid motion makes them tricky to track.
Only one of the known Venus co-orbital asteroids follows a nearly circular orbit; the others move on more elongated paths that sometimes bring them closer to Earth, making them easier to detect. However, Carruba's team believes this pattern may reflect observational bias, not the actual makeup of the population.
"It's impossible to say for sure," he said, "but I suspect we will find hundreds of asteroids around Venus."
To test this idea, Carruba's team ran computer simulations modeling the orbits of hundreds of hypothetical Venus co-orbital asteroids, projecting their paths up to 36,000 years into the future.
They found that many of these objects can remain gravitationally bound to Venus' orbit for an average of about 12,000 years. Of note, the orbits of the objects appeared chaotic, meaning small shifts over time can push them onto different paths, including some that bring them close to Earth.
There's no cause for concern right now; none of the known asteroids pose any threat, and the timescales involved span many thousands of years.
"The likelihood of one colliding with Earth any time soon is extremely low," Scott Sheppard, an astronomer at the Carnegie Institution for Science in Washington, D.C. who was not involved with the new study, told National Geographic. "There isn't too much to be worried about here."
In a study published earlier this year in the journal Icarus, Carruba's team analyzed the orbital evolution of the 20 known Venus co-orbital asteroids. Their simulations showed that three of these objects — each measuring between 1,000 and 1,300 feet (300 to 400 meters) across — could eventually pass within about 46,500 miles (74,800 kilometers) of Earth's orbit. In some cases, this gradual shift onto a near-Earth trajectory could take up to 12,000 years.
Keeping track of such objects and understanding how they move is crucial for building a more complete picture of near-Earth space, the new study argues.
"We should know about these objects," said Carruba. "They are very interesting dynamically — I think that would be a reason to continue to study them."
Because Venus' asteroids are so difficult to spot from Earth, Carruba's team explored how we might do better from other vantage points. Their simulations showed that a spacecraft orbiting closer to Venus would have a much better chance of detecting these fast-moving asteroids.
Related Stories:
— The Rubin Observatory found 2,104 asteroids in just a few days. It could soon find millions more
— Europe wants to land a tiny spacecraft on the infamous asteroid Apophis in 2029
— Astronomers discover the largest comet from the outskirts of the solar system is exploding with jets of gas
The upcoming Vera C. Rubin Observatory, which just released its first images on June 23,, could also help. Although it's not specifically built to focus on the inner solar system, its special twilight observing campaigns might be able to catch some of these hidden asteroids. In fact, the observatory has already identified 2,104 new asteroids in its initial datasets.
Further into the future, a proposed mission concept called CROWN could offer an even more targeted approach. The mission concept envisions a fleet of small spacecraft operating near Venus' orbit, designed specifically to search for asteroids in the inner solar system.
These efforts "may be able to discover a lot of these objects, if they exist," said Carruba.
This research was posted to arXiv on May 21 and will be published in the journal Astronomy and Astrophysics.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Health Line
4 hours ago
- Health Line
What We Know About CBD for Macular Degeneration (AMD)
CBD has similar pain-relieving effects to THC but isn't psychoactive. Early research suggests CBD may help AMD, but it is not endorsed by doctors. Age-related macular degeneration (AMD) is a leading cause of vision loss in the United States, with age and family being primary risk factors. While healthcare professionals do not currently recommend cannabis and CBD as a treatment option for macular degeneration or other eye health issues, ongoing research suggests it may one day be a possible treatment option for some people with this eye condition. Do CBD treatments help with macular degeneration? About macular degeneration treatments There are two kinds of age-related macular degeneration. Dry AMD is more common. Treatment for dry AMD includes taking specific nutritional supplements and using low-vision aids. Wet AMD is not as common, but it's more treatable. Treatments include anti-vascular endothelial growth factor (VEGF) eye injections and light therapy. Generally, cannabis use is linked to lowered eye pressure and is known to help lower inflammation throughout the body. Some people with AMD have reported anecdotal benefits from CBD use. This 2022 research in the United Kingdom (IK) does indicate that CBD may possibly lower the risk of this eye condition. However, there's not enough medical research overall to support CBD as a treatment for any type of AMD. In the UK study looking at people who'd used marijuana (including CBD) more than 100 times, they did see a lower risk for AMD. But the research also indicated people experienced higher rates of blood vessel loss, possibly leading to AMD development sooner for younger people. Research on this topic has also found that many forms of CBD can't be easily administered as treatments for eye conditions. For instance, CBD oils aren't the right consistency to be made into eye drops. Can you use CBD for other eye conditions? CBD is known to have an effect on eye pressure, which could be a meaningful benefit for acute or chronic eye conditions. For example, glaucoma is an eye condition that can lead to permanent vision loss, but it has a different cause than AMD. It's often caused by a buildup of eye pressure on your optic nerve (it sends visual information from your eyes to your brain). Lowering eye pressure could potentially lower the risk of glaucoma and help treat active cases. But research is conflicting and shows there may also be side effects of using CBD for glaucoma or other eye conditions, including mental health concerns, vision changes such as color blindness, retinal deterioration, and optic nerve damage. No enough research exists to support CBD as a treatment for eye pressure or as a way to lower the risk of either glaucoma or AMD. Results are conflicting. A 2018 study found that CBD (cannabidiol) eye drops increased eye pressure in rats. But the same study found that THC (tetrahydrocannabinol) eye drops reduced eye pressure by up to 30%. Treatment of AMD and glaucoma isn't the only possible eye-health-related use of CBD. Research is also being done into the use of CBD to help treat: diabetic retinopathy eye inflammation corneal inflammation eye pain Additional research is needed to determine if CBD or THC could be used in glaucoma or AMD treatment and prevention. Right now neither is approved for managing these conditions. Traditional AMD treatments Traditional, scientifically backed AMD treatment regimens depend on the type of AMD you have. They may include. Anti-VEGF injections: These injections are the most common treatment for wet AMD. They stop the growth of eye blood vessels and can prevent and possibly reverse vision loss. Light therapy: Known as photodynamic therapy, this treatment type may also be used to target and destroy blood vessels. Nutritional supplements: A combination of nutritional supplements known as the AREDS2 formula has been shown to help prevent further vision loss due to dry AMD. However, these supplements aren't proven to lower the chance of AMD onset overall. Low vision aids: These can help with any vision loss you experience due to either form of AMD or another condition. They are an essential tool in managing dry AMD. An eye doctor can help you determine the best options for you. Options may include wearing glasses, using a magnifying glass, large print materials, and an array of computer programs or mobile apps. How can you prevent macular degeneration? AMD is tied to multiple risk factors, many of which you can't control including age and genetics passed down through families. However, you can practice habits to support good eye health, which benefits your eyes lifelong. These may include: Getting regular eye exams. Don't smoke or quit smoking. Getting regular physical activity. Eating certain foods that may help your eye health, including low cholesterol foods.
Yahoo
4 hours ago
- Yahoo
Massive Review Finds No 'Safe' Level of Processed Meat Consumption
We know that processed meat isn't particularly good for us, having already been linked to dementia, diabetes, and cancer, but how much of it counts as a 'safe' level of consumption? According to new research, there's no such thing. US researchers reviewed over 70 previous studies (involving several million participants in total), analyzing the relationships between ultra-processed food and three health issues: type 2 diabetes, ischemic heart disease, and colorectal cancer. Associations for processed meat, sugar-sweetened beverages, and trans fatty acids were looked into, and it was the processed meat that came out with the worst results – even if the amount eaten is only small. "The monotonic increases in health risk with increased consumption of processed meat suggest that there is not a 'safe' amount of processed meat consumption with respect to diabetes or colorectal cancer risk," the team from the University of Washington in Seattle writes in their published paper. Related: It's important to put the research into context. The associations found are relatively weak, they don't prove direct cause and effect, and the analyzed studies relied on self-reported dietary habits (which may not be completely accurate). However, the study has several strengths too – it uses a Burden of Proof method, which is more conservative when assessing impacts on health. The results tend to be minimum values, which means they likely underestimate the true health risk. What's particularly notable here is that minimal increases in consumption still raised risk levels. "Habitual consumption of even small amounts of processed meat, sugary drinks, and trans fatty acids is linked to increased risk of developing type 2 diabetes, ischemic heart disease and colorectal cancer," University of Washington nutrition biologist Demewoz Haile told CNN. For example, the equivalent of one hot dog a day was associated with at least an 11 percent greater risk of type 2 diabetes, and at least a 7 percent greater risk of colorectal cancer, compared to eating no processed meat at all. For beverages, an extra can of sugar-sweetened pop a day was linked to a 8 greater risk of type 2 diabetes, and a 2 percent greater risk of ischemic heart disease, compared to not drinking anything sugary. For trans fatty acids, a small daily amount was associated with a 3 percent increase in risk of ischemic heart disease, compared with zero consumption. "This information provides critical data for public health specialists and policymakers responsible for dietary guidelines and potential initiatives that aim to reduce the consumption of these processed foods," write the researchers. While the study has limitations, its scale and conservative methodology make it worth taking note of. This is backed up by a commentary in the same journal, which does note the role of ultra-processed foods in improving food accessibility and shelf life, particularly in areas with limited access to fresh food. The message from the research team is that cutting out ultra-processed foods as much as possible is the best option for our health. The research has been published in Nature Medicine. Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds Gut Bacteria Found to Soak Up Toxic Forever Chemicals Gene Therapy Can Restore Hearing in Adults, First-of-Its-Kind Trial Shows
Yahoo
4 hours ago
- Yahoo
Mysterious Leprosy Pathogen Has Lurked in The Americas For 4,000 Years
A new study has found that leprosy was circulating in Chile some 4,000 years ago, meaning the disease arrived in the Americas much earlier than previously thought. That's based on an analysis of ancient bones and teeth by researchers from institutions in Germany, Argentina, and Chile, and it challenges the conventional wisdom that leprosy was a disease introduced by European settlers from the 16th century onwards. Through a comprehensive study of DNA fragments found in two human skeletons, the researchers were able to match the genetic material to the Mycobacterium lepromatosis pathogen – the less common of two bacteria known to cause leprosy. "We were initially suspicious, since leprosy is regarded as a colonial-era disease, but more careful evaluation of the DNA revealed the pathogen to be of the lepromatosis form," says anthropologist Darío Ramirez, from the National University of Córdoba in Argentina. Related: Scientists are still learning about M. lepromatosis, which has only recently been identified. Another bacteria, Mycobacterium leprae, is the dominant strain behind leprosy, and its history and spread has been more clearly mapped to date. While there's a scarcity of samples in the Americas, M. leprae has been tracked back for thousands of years across Eurasia, which is part of the reason why researchers have long thought it traveled from Europe across the Atlantic. Another recent study found traces of M. lepromatosis in remains from Canada and Argentina, stretching back at least a thousand years – again before European settlers showed up. This new find, pushing its arrival back millennia earlier, adds further evidence that we need to rethink the history of leprosy. "Ancient DNA has become a great tool that allows us to dig deeper into diseases that have had a long history in the Americas," says anthropologist Kirsten Bos, from the Max Planck Institute for Evolutionary Anthropology in Germany. "The advanced techniques now used to study ancient pathogen DNA allows us to look beyond the suspects and into other diseases that might not be expected from the context." Trying to pick apart this history of disease isn't easy. Indigenous American peoples would certainly have had afflictions of their own, but they would have also been hit hard by infections imported by colonists – infections their bodies were poorly prepared for. The researchers are confident that there's more to the story, in terms of both modern and ancient forms of the disease – especially in regards to M. lepromatosis. Each archaeological dig and clinical test gives experts more genomes to work with, which then further helps our understanding of disease history, spread, and diversification. Part of the skill needed by researchers is knowing what to look for, which is highlighted by this study – previous work in this area may have missed ancient markers of leprosy, simply because no one thought to look for it. "This disease was present in Chile as early as 4,000 years ago, and now that we know it was there, we can specifically look for it in other contexts," says anthropologist Rodrigo Nores, from the National University of Córdoba. The research has been published in Nature Ecology & Evolution. Massive Review Finds No 'Safe' Level of Processed Meat Consumption Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds Gut Bacteria Found to Soak Up Toxic Forever Chemicals